Lung cancer screening in the gulf: Rationale and recommendations

Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable...

Full description

Saved in:
Bibliographic Details
Published inAnnals of thoracic medicine Vol. 17; no. 4; pp. 189 - 192
Main Authors Bennji, Sami, Jayakrishnan, B, Al-Kindi, Adil, Al-Jahdhami, Issa, Al-Hashami, Zamzam
Format Journal Article
LanguageEnglish
Published Mumbai Wolters Kluwer India Pvt. Ltd 01.10.2022
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
Brief Report
Cancer
Diagnosis
Health aspects
low-dose computed tomography
Lung cancer
lung cancer screening
Lung cancer screening
Lung cancer
Low-dose computed tomography
Online AccessGet full text

Cover

More Information
Summary:Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1817-1737
1998-3557
DOI:10.4103/atm.atm_69_22